Inventor · disambiguated record
Jens Larsen
Also filed as: LARSEN JENS · LARSEN JENS C HØJLAND · LARSEN JENS CHRISTIAN HOEJLAND · LARSEN JENS CHRISTIAN HOJLAND
13 granted patents·9 pending applications·36 citations·filing 2003–2022
89Inventor score
Files withLEO PHARMA AS9NOVO NORDISK AS4UNION THERAPEUTICS AS4BOLLU RAVINDRA BABU1KNUDSEN LISELOTTE B1
Top patents by PatentIndex Score
22 records- 0190US11365204B2Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitorsUNION THERAPEUTICS AS·Filed 2018·Granted Jun 21, 2022·5 cites·17 claims
- 0289US11866445B2Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitorsUNION THERAPEUTICS AS·Filed 2022·Granted Jan 9, 2024·1 cites·28 claims
- 0389US11292799B2Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitorsUNION THERAPEUTICS AS·Filed 2018·Granted Apr 5, 2022·5 cites·12 claims
- 0487US11065257B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2017·Granted Jul 20, 2021·3 cites·9 claims
- 0582US10906915B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 0682US10793580B2Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2016·Granted Oct 6, 2020·3 cites·13 claims
- 0782US9181248B2[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2014·Granted Nov 10, 2015·5 cites·1 claims
- 0881US11299497B2Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitorsUNION THERAPEUTICS AS·Filed 2018·Granted Apr 12, 2022·2 cites·12 claims
- 0977US8940761B2[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2012·Granted Jan 27, 2015·3 cites·10 claims
- 1076US8338431B2Phosphodiesterase inhibitorsBOLLU RAVINDRA BABU·Filed 2008·Granted Dec 25, 2012·5 cites·25 claims
- 1168US8350026B2VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2009·Granted Jan 8, 2013·1 cites·11 claims
- 1262US2022362259A1Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2021·Application pending·0 cites
- 1359US2009215688A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1457US2014206615A1Glp-1 agonist and cardiovascular complicationsNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 1556US2013338071A1GLP-1 Agonist and Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 1655US2007049531A1GLP-1 agonist and cardiovascular complationsKNUDSEN LISELOTTE B·Filed 2006·Application pending·0 cites
- 1752US2012295836A1GLP-I Agonist And Cardiovascular ComplicationsKNUDSEN LISELOTTE BJERRE·Filed 2012·Application pending·0 cites
- 1851US2011230409A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 1948US10703751B2Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
- 2046US2003220255A1GLP-1 agonist and cardiovascular complicationsFiled 2003·Application pending·0 cites
- 2145US2021269447A1Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2019·Application pending·0 cites
- 2235US9051290B2Biaryl phosphodiesterase inhibitorsNIELSEN SIMON FELDBÆK·Filed 2011·Granted Jun 9, 2015·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Jens Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →